How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

RX

NASDAQ:RXDX
Get a brief AI stock analysisSaves ~ 15 minutes of your time

RX

Prometheus Biosciences IncNASDAQ RXDX Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

XNAS - Nasdaq

FAIR VALUE

Is RXDX undervalued compared to its fair value?

The fair value of RXDX stock is hidden USD. Relative to the market price of 0 USD Prometheus Biosciences Inc is hidden.

Prometheus Biosciences, Inc. engages in operation of a biopharmaceutical company. The company is headquartered in San Diego, California and currently employs 97 full-time employees. The company went IPO on 2021-03-11. Th...[More about valuation]

Prometheus Biosciences Fair Value

hidden
UNLOCK
What is fair value?

Market cap:

9.559 $B

Price:

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

-0.861

FINANCIALS

Prometheus Biosciences financial for reporting period

Income Statement

0.0011 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.049 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.041 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

0.0011 B 100%
-0.049 B -4408%
-0.041 B -3699%

Balance Sheet

0.76 B
0.7 B

Financial Position Analysis

Assets

0.76 B
Current Assets
0.73 B
Total non-current assets
0.032 B

Total current liabilities
0.019 B
Total non-current liabilities
0.041 B

Cash Flow Statement

-0.04 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.04 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Prometheus Biosciences fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators

-33 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-895 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-30 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Is RXDX attractive for investment based on fundamental analysis?

RXDX stock rating is hidden. Prometheus Biosciences is a hidden by Eyestock methodology.

Get RXDX Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

-3 769

Gross Margin:

CFO / Debt ratio:

hidden

Current ratio:

23.3

Debt / Equity ratio:

ROE:

-33

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

RXDX analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for RXDX to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

Prometheus Biosciences Inc competitors

AB

ABBV

Abbvie Inc

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. The company is headquartered in North Chicago, Ill...

Discover

AM

AMGN

Amgen Inc

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. The Company...

Discover

VR

VRTX

Vertex Pharmaceuticals Inc

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs fo...

Discover

Prometheus Biosciences Inc dividends

RXDX dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About RXDX stock

About the company Prometheus Biosciences Inc

Market cap $B

9.559

Dividend yield

Shares outstanding

47.5303 B

Prometheus Biosciences, Inc. engages in operation of a biopharmaceutical company. The company is headquartered in San Diego, California and currently employs 97 full-time employees. The company went IPO on 2021-03-11. The firm is engaged in discovery, development, and commercialization of therapeutic and companion diagnostic products for the treatment of immune-mediated diseases, such as inflammatory bowel disease (IBD). The firm's precision medicine platform Prometheus360, which includes gastrointestinal (GI) bioinformatics databases, to identify therapeutic targets and develop therapeutic candidates to engage the targets. Its product pipeline includes PRA023, PR600, PR300, PR1100, PR1800 and PR2100. The firm's lead product candidate PRA023, is an IgG1 humanized monoclonal antibody (mAb) designed to target both inflammation and fibrosis associated with IBD. The company has focused on developing PRA023 for the treatment of ulcerative colitis (UC) and Crohn's disease (CD).

RXDX profile

  • Ticker

    RXDX

  • Country

    USA

  • Exchange

    XNAS - Nasdaq

  • Report currency

    USD - US dollar

  • IPO date

    11 March 2021

  • Sector

    Healthсare

  • Industry

    Biotechnology

  • Employees

    97

  • City

    San Diego

  • Address

    3050 Science Park Road, #342

  • Cusip

    74349U108